Using GM-CSF as a Host Directed Therapeutic Against COVID-19

NCT04400929 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

COVID
Sars-CoV2
ARDS, Human

Interventions

DRUG: Sargramostim
OTHER: Normal Saline 0.9%

Sponsor

Singapore General Hospital